McDaniel Terry & Co
- SEC CIK
- 0001104366
- Latest filing
- Jul 30, 2026
ABT holding history
Abbott Laboratories in every 13F filed by McDaniel Terry & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q2 2026)
- 13,281
- Value
- $1.21M
- % of portfolio
- 0.1%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 13,281 | $1.21M | 0.1% | −119−0.9% | Reduced | Holders |
| Q1 2026 | 13,400 | $1.38M | 0.1% | +1,012+8.2% | Added | Holders |
| Q4 2025 | 12,388 | $1.55M | 0.1% | −5,828−32.0% | Reduced | Holders |
| Q3 2025 | 18,216 | $2.44M | 0.2% | +10+0.1% | Added | Holders |
| Q2 2025 | 18,206 | $2.48M | 0.2% | +53+0.3% | Added | Holders |
| Q1 2025 | 18,153 | $2.41M | 0.2% | −25−0.1% | Reduced | Holders |
| Q4 2024 | 18,178 | $2.06M | 0.2% | +10+0.1% | Added | Holders |
| Q3 2024 | 18,168 | $2.07M | 0.2% | −130−0.7% | Reduced | Holders |
| Q2 2024 | 18,298 | $1.90M | 0.2% | −40−0.2% | Reduced | Holders |
| Q1 2024 | 18,338 | $2.08M | 0.2% | −1,310−6.7% | Reduced | Holders |
| Q4 2023 | 19,648 | $2.16M | 0.2% | −910−4.4% | Reduced | Holders |
| Q3 2023 | 20,558 | $1.99M | 0.2% | +3,160+18.2% | Added | Holders |
| Q2 2023 | 17,398 | $1.90M | 0.2% | −227−1.3% | Reduced | Holders |
| Q1 2023 | 17,625 | $1.78M | 0.2% | +17,625 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −14,682−100.0% | Sold out | Holders |
| Q2 2021 | 14,682 | $1.70M | 0.2% | +70.0% | Added | Holders |
| Q1 2021 | 14,675 | $1.76M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.